Vaccination

AstraZeneca, Oxford Uni buoyed by vaccine response

British pharma giant AstraZeneca said on Monday trials of its coronavirus vaccine pioneered with Oxford University had shown "encouraging" responses among elderly, as well as younger participants.

Diseases, Conditions, Syndromes

Brazil's Bolsonaro rejects Chinese vaccine against COVID-19

Brazil's President Jair Bolsonaro rejected on Wednesday the announced purchase of 46 million doses of a potential vaccine against COVID-19 being developed by a Chinese company and tested in the state governed by his political ...

Diseases, Conditions, Syndromes

S. Africa to start Africa's first coronavirus vaccine pilot

South Africa will roll out the continent's first coronavirus vaccine trial this week, the university leading the pilot said Tuesday, as the country grapples with the highest number of cases in Africa.

Diseases, Conditions, Syndromes

AstraZeneca agrees to make COVID-19 vaccine for Europe

Drugmaker AstraZeneca struck a deal Saturday to supply up to 400 million doses of an experimental COVID-19 vaccine to European Union countries, the latest in a series of agreements as scientists, governments and pharmaceutical ...

page 2 from 4